...  under: drug treatment centers in georgia An ongoing Phase 2 pivotal trial of a potential drug to treat certain types of leukemia which is being developed by Ariad Pharmaceuticals Inc. (Nasdaq: ARIA) found a majority of the 444 patients enrolled are cancer-free after a year. … spokeswoman … Read more on Boston Business Journal (blog)  Cyclacel Presents Updated Survival Data From the Pilot Study and Lead-In … Filed under: drug treatment centers in georgia The FDA and the European Medicines Agency have designated sapacitabine as an orphan drug for the treatment of both AML and MDS. Sapacitabine is part of Cyclacel's pipeline of small molecule drugs designed to target and stop uncontrolled cell division. Read more on NASDAQ Tags: european medicines agency, drug treatment center, treatment center, Drug Treatment Centers ...